SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:6b8034c4-6268-447d-bd2a-f6e5e313ae29"
 

Search: onr:"swepub:oai:lup.lub.lu.se:6b8034c4-6268-447d-bd2a-f6e5e313ae29" > Orthotopic Bone For...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Pigeot, SébastienUniversity Hospital Basel (author)

Orthotopic Bone Formation by Streamlined Engineering and Devitalization of Human Hypertrophic Cartilage

  • Article/chapterEnglish2020

Publisher, publication year, extent ...

  • 2020-09-30
  • MDPI AG,2020

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:6b8034c4-6268-447d-bd2a-f6e5e313ae29
  • https://lup.lub.lu.se/record/6b8034c4-6268-447d-bd2a-f6e5e313ae29URI
  • https://doi.org/10.3390/ijms21197233DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Most bones of the human body form and heal through endochondral ossification, whereby hypertrophic cartilage (HyC) is formed and subsequently remodeled into bone. We previously demonstrated that HyC can be engineered from human mesenchymal stromal cells (hMSC), and subsequently devitalized by apoptosis induction. The resulting extracellular matrix (ECM) tissue retained osteoinductive properties, leading to ectopic bone formation. In this study, we aimed at engineering and devitalizing upscaled quantities of HyC ECM within a perfusion bioreactor, followed by in vivo assessment in an orthotopic bone repair model. We hypothesized that the devitalized HyC ECM would outperform a clinical product currently used for bone reconstructive surgery. Human MSC were genetically engineered with a gene cassette enabling apoptosis induction upon addition of an adjuvant. Engineered hMSC were seeded, differentiated, and devitalized within a perfusion bioreactor. The resulting HyC ECM was subsequently implanted in a 10-mm rabbit calvarial defect model, with processed human bone (Maxgraft®) as control. Human MSC cultured in the perfusion bioreactor generated a homogenous HyC ECM and were efficiently induced towards apoptosis. Following six weeks of in vivo implantation, microcomputed tomography and histological analyses of the defects revealed an increased bone formation in the defects filled with HyC ECM as compared to Maxgraft®. This work demonstrates the suitability of engineered devitalized HyC ECM as a bone substitute material, with a performance superior to a state-of-the-art commercial graft. Streamlined generation of the devitalized tissue transplant within a perfusion bioreactor is relevant towards standardized and automated manufacturing of a clinical product.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Bourgine, Paul EmileLund University,Lunds universitet,Molekylär skelettbiologi,Forskargrupper vid Lunds universitet,WCMM- Wallenberg center för molekylär medicinsk forskning,Medicinska fakulteten,Molecular Skeletal Biology,Lund University Research Groups,WCMM-Wallenberg Centre for Molecular Medicine,Faculty of Medicine,University Hospital Basel(Swepub:lu)pa2431bo (author)
  • Claude, JaquieryUniversity Hospital Basel (author)
  • Scotti, CelesteNovartis Institutes for BioMedical Research, Inc.,Istituto Ortopedico Galeazzi (author)
  • Papadimitropoulos, AdamUniversity Hospital Basel (author)
  • Todorov, AtanasUniversity Hospital Basel (author)
  • Epple, ChristianUniversity Hospital Basel (author)
  • Peretti, Giuseppe MIstituto Ortopedico Galeazzi,University of Milan (author)
  • Martin, IvanUniversity Hospital Basel (author)
  • University Hospital BaselMolekylär skelettbiologi (creator_code:org_t)

Related titles

  • In:International Journal of Molecular Sciences: MDPI AG21:191422-0067

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view